A Comprehensive Guide to Studying Inflammasome Activation and Cell Death

Overview

Journal Nat Protoc

Specialties Biology
Pathology
Science

Date 2020 Sep 8

PMID 32895525

Citations 27

Authors

Rebecca E Tweedell

R K Subbarao Malireddi

Thirumala-Devi Kanneganti

Affiliations

Soon will be listed here.

Abstract

Inflammasomes are multimeric heterogeneous mega-Dalton protein complexes that play key roles in the host innate immune response to infection and sterile insults. Assembly of the inflammasome complex following infection or injury begins with the oligomerization of the upstream inflammasome-forming sensor and proceeds through a multistep process of well-coordinated events and downstream effector functions. Together, these steps enable elegant experimental readouts with which to reliably assess the successful activation of the inflammasome complex and cell death. Here, we describe a comprehensive protocol that details several in vitro (in bone marrow-derived macrophages) and in vivo (in mice) strategies for activating the inflammasome and explain how to subsequently assess multiple downstream effects in parallel to unequivocally establish the activation status of the inflammasome and cell death pathways. Our workflow assesses inflammasome activation via the formation of the apoptosis-associated speck-like protein containing a CARD (ASC) speck; cleavage of caspase-1 and gasdermin D; release of IL-1β, IL-18, caspase-1, and lactate dehydrogenase from the cell; and real-time analysis of cell death by imaging. Analyses take up to ~24 h to complete. Overall, our multifaceted approach provides a comprehensive and consistent protocol for assessing inflammasome activation and cell death.

Citing Articles

Fucosylated haptoglobin promotes inflammation via Mincle in sepsis: an observational study.

Roh T, Ju S, Park S, Ahn Y, Chung J, Nakano M Nat Commun. 2025; 16(1):1342.

PMID: 39904983 PMC: 11794430. DOI: 10.1038/s41467-025-56524-3.

The Predictive Value of Lactate Dehydrogenase for Viral Suppression in Newly Diagnosed People Living With HIV on Antiretroviral Therapy: A Retrospective Cohort Study.

Jin Y, Wang Y, Xia T, Ma Q Infect Drug Resist. 2025; 18:601-611.

PMID: 39902274 PMC: 11789517. DOI: 10.2147/IDR.S488220.

The protein phosphatase PP6 promotes RIPK1-dependent PANoptosis.

Bynigeri R, Malireddi R, Mall R, Connelly J, Pruett-Miller S, Kanneganti T BMC Biol. 2024; 22(1):122.

PMID: 38807188 PMC: 11134900. DOI: 10.1186/s12915-024-01901-5.

Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children.

Zhang Z, Kean I, Dratva L, Clark J, Syrimi E, Khan N Nat Commun. 2024; 15(1):4227.

PMID: 38762592 PMC: 11102542. DOI: 10.1038/s41467-024-48699-y.

Flagellin-modulated inflammasome pathways characterize the human alveolar macrophage response to , a lung-tropic pathogen.

Lovelace-Macon L, Baker S, Ducken D, Seal S, Rerolle G, Tomita D Infect Immun. 2024; 92(5):e0006024.

PMID: 38619302 PMC: 11075458. DOI: 10.1128/iai.00060-24.

References

Kesavardhana S, Kanneganti T . Mechanisms governing inflammasome activation, assembly and pyroptosis induction. Int Immunol. 2017; 29(5):201-210. PMC: 5890894. DOI: 10.1093/intimm/dxx018. View

Man S, Karki R, Kanneganti T . Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017; 277(1):61-75. PMC: 5416822. DOI: 10.1111/imr.12534. View

Martinon F, Burns K, Tschopp J . The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002; 10(2):417-26. DOI: 10.1016/s1097-2765(02)00599-3. View

Kanneganti T, Lamkanfi M, Nunez G . Intracellular NOD-like receptors in host defense and disease. Immunity. 2007; 27(4):549-59. DOI: 10.1016/j.immuni.2007.10.002. View

Liston A, Masters S . Homeostasis-altering molecular processes as mechanisms of inflammasome activation. Nat Rev Immunol. 2017; 17(3):208-214. DOI: 10.1038/nri.2016.151. View

Tartey S, Kanneganti T . Inflammasomes in the pathophysiology of autoinflammatory syndromes. J Leukoc Biol. 2019; 107(3):379-391. PMC: 7044027. DOI: 10.1002/JLB.3MIR0919-191R. View

Man S, Kanneganti T . Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol. 2015; 16(1):7-21. PMC: 4915362. DOI: 10.1038/nri.2015.7. View

Brydges S, Broderick L, McGeough M, Pena C, Mueller J, Hoffman H . Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. J Clin Invest. 2013; 123(11):4695-705. PMC: 3809806. DOI: 10.1172/JCI71543. View

Hoffman H, Mueller J, Broide D, Wanderer A, Kolodner R . Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001; 29(3):301-5. PMC: 4322000. DOI: 10.1038/ng756. View

10.

Brydges S, Mueller J, McGeough M, Pena C, Misaghi A, Gandhi C . Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity. 2009; 30(6):875-87. PMC: 2759865. DOI: 10.1016/j.immuni.2009.05.005. View

11.

Sharma D, Sharma B, Vogel P, Kanneganti T . IL-1β and Caspase-1 Drive Autoinflammatory Disease Independently of IL-1α or Caspase-8 in a Mouse Model of Familial Mediterranean Fever. Am J Pathol. 2016; 187(2):236-244. PMC: 5389372. DOI: 10.1016/j.ajpath.2016.10.015. View

12.

Chae J, Cho Y, Lee G, Cheng J, Liu P, Feigenbaum L . Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity. 2011; 34(5):755-68. PMC: 3129608. DOI: 10.1016/j.immuni.2011.02.020. View

13.

Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P . Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol. 2009; 161(5):1199-201. DOI: 10.1111/j.1365-2133.2009.09404.x. View

14.

Yu J, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, Solorzano L . Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell. 2007; 28(2):214-27. PMC: 2719761. DOI: 10.1016/j.molcel.2007.08.029. View

15.

Karki R, Kanneganti T . Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019; 19(4):197-214. PMC: 6953422. DOI: 10.1038/s41568-019-0123-y. View

16.

Sharma D, Kanneganti T . The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation. J Cell Biol. 2016; 213(6):617-29. PMC: 4915194. DOI: 10.1083/jcb.201602089. View

17.

Boyden E, Dietrich W . Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet. 2006; 38(2):240-4. DOI: 10.1038/ng1724. View

18.

Kanneganti T, Ozoren N, Body-Malapel M, Amer A, Park J, Franchi L . Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 2006; 440(7081):233-6. DOI: 10.1038/nature04517. View

19.

Sutterwala F, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger G, Grant E . Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006; 24(3):317-27. DOI: 10.1016/j.immuni.2006.02.004. View

20.

Mariathasan S, Weiss D, Newton K, McBride J, ORourke K, Roose-Girma M . Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006; 440(7081):228-32. DOI: 10.1038/nature04515. View